Xtant Medical Holdings Inc (XTNT)
0.95
+0.05
(+5.38%)
USD |
NYAM |
Apr 26, 16:00
0.94
-0.01
(-1.05%)
Pre-Market: 20:00
Xtant Medical Holdings Revenue (Quarterly): 28.11M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 28.11M |
| September 30, 2023 | 25.02M |
| June 30, 2023 | 20.23M |
| March 31, 2023 | 17.94M |
| December 31, 2022 | 15.27M |
| September 30, 2022 | 14.46M |
| June 30, 2022 | 15.28M |
| March 31, 2022 | 12.96M |
| December 31, 2021 | 13.97M |
| September 30, 2021 | 13.78M |
| June 30, 2021 | 14.98M |
| March 31, 2021 | 12.54M |
| December 31, 2020 | 14.02M |
| September 30, 2020 | 14.02M |
| June 30, 2020 | 10.53M |
| March 31, 2020 | 14.78M |
| December 31, 2019 | 16.96M |
| September 30, 2019 | 15.72M |
| June 30, 2019 | 15.27M |
| March 31, 2019 | 16.73M |
| December 31, 2018 | 18.26M |
| September 30, 2018 | 17.27M |
| June 30, 2018 | 18.74M |
| March 31, 2018 | 17.93M |
| December 31, 2017 | 19.33M |
| Date | Value |
|---|---|
| September 30, 2017 | 19.79M |
| June 30, 2017 | 21.41M |
| March 31, 2017 | 22.08M |
| December 31, 2016 | 24.47M |
| September 30, 2016 | 23.09M |
| June 30, 2016 | 21.46M |
| March 31, 2016 | 20.98M |
| December 31, 2015 | 22.26M |
| September 30, 2015 | 17.69M |
| June 30, 2015 | 9.893M |
| March 31, 2015 | 9.503M |
| December 31, 2014 | 9.081M |
| September 30, 2014 | 8.454M |
| June 30, 2014 | 8.884M |
| March 31, 2014 | 8.913M |
| December 31, 2013 | 8.258M |
| September 30, 2013 | 7.93M |
| June 30, 2013 | 8.267M |
| March 31, 2013 | 8.619M |
| December 31, 2012 | 8.122M |
| September 30, 2012 | 8.880M |
| June 30, 2012 | 8.208M |
| March 31, 2012 | 7.77M |
| December 31, 2011 | 9.101M |
| September 30, 2011 | 7.540M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
10.53M
Minimum
Jun 2020
28.11M
Maximum
Dec 2023
16.10M
Average
14.98M
Median
Jun 2021
Revenue (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -5.239M |
| Retractable Technologies Inc | 14.29M |
| InfuSystems Holdings Inc | 31.77M |
| Asensus Surgical Inc | 5.431M |
| Catheter Precision Inc | 0.128M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.303M |
| Total Expenses (Quarterly) | 31.91M |
| EPS Diluted (Quarterly) | -0.03 |
| Enterprise Value | 139.78M |
| Gross Profit Margin (Quarterly) | 60.97% |
| Profit Margin (Quarterly) | -15.31% |
| Normalized Earnings Yield | -7.330 |